Related references
Note: Only part of the references are listed.European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update
Morgan Roupret et al.
EUROPEAN UROLOGY (2021)
The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma
Keisuke Shigeta et al.
CANCER SCIENCE (2021)
Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma
Sreenivas Nannapaneni et al.
PLOS ONE (2021)
Pparg signaling controls bladder cancer subtype and immune exclusion
Tiffany Tate et al.
NATURE COMMUNICATIONS (2021)
Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma
Firas G. Petros et al.
JOURNAL OF UROLOGY (2021)
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?
Bas W. G. van Rhijn et al.
EUROPEAN UROLOGY (2020)
CK20 and CK5/6 Immunohistochemical Staining of Urothelial Neoplasms: A Perspective
Mohammed Akhtar et al.
ADVANCES IN UROLOGY (2020)
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
Y. Loriot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Predicting outcomes in non-muscle invasive (Ta/T1) bladder cancer: the role of molecular grade based on luminal/basal phenotype
Jorge Rebola et al.
VIRCHOWS ARCHIV (2019)
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
Brian D. Robinson et al.
NATURE COMMUNICATIONS (2019)
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma
Francois Audenet et al.
CLINICAL CANCER RESEARCH (2019)
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review
Viktor Soukup et al.
EUROPEAN UROLOGY (2017)
Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment
D. Pouessel et al.
ANNALS OF ONCOLOGY (2016)
Recent advances in renal cell carcinoma from a pathological point of view
Shuji Mikami et al.
PATHOLOGY INTERNATIONAL (2016)
A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma
Thomas Seisen et al.
EUROPEAN UROLOGY (2015)
Genomic Characterization of Upper Tract Urothelial Carcinoma
John P. Sfakianos et al.
EUROPEAN UROLOGY (2015)
Comprehensive molecular characterization of urothelial bladder carcinoma
John N. Weinstein et al.
NATURE (2014)
Increased angiogenesis and FGFR protein expression indicate a favourable prognosis in bladder cancer
Simone Bertz et al.
VIRCHOWS ARCHIV (2014)
The prognostic significance of vasohibin-1 expression in patients with prostate cancer
T. Kosaka et al.
BRITISH JOURNAL OF CANCER (2013)
Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma
Kwang Hyun Kim et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Expression and prognostic significance of Src family members in renal clear cell carcinoma
T. Qayyum et al.
BRITISH JOURNAL OF CANCER (2012)
The Impact of Tumor Multifocality on Outcomes in Patients Treated With Radical Nephroureterectomy
Thomas F. Chromecki et al.
EUROPEAN UROLOGY (2012)
The FGFR3 Mutation is Related to Favorable pT1 Bladder Cancer
Bas W. G. van Rhijn et al.
JOURNAL OF UROLOGY (2012)
Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial Carcinoma
Eiji Kikuchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract
C Hafner et al.
ONCOGENE (2001)
Share Paper
